Nuvation Bio (NUVB) News Today $2.13 -0.01 (-0.23%) Closing price 07/15/2025 03:59 PM EasternExtended Trading$2.12 -0.02 (-0.94%) As of 07/15/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NUVB Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Nuvation Bio (NYSE:NUVB) Stock Price Down 5.2% - Should You Sell?July 14 at 5:27 PM | marketbeat.comAll You Need to Know About Nuvation Bio (NUVB) Rating Upgrade ... - NasdaqJuly 11, 2025 | nasdaq.comAnalysts Set Nuvation Bio Inc. (NYSE:NUVB) PT at $7.17July 10, 2025 | americanbankingnews.comNuvation Bio (NYSE:NUVB) Shares Gap Up - What's Next?July 9, 2025 | marketbeat.comNuvation Bio Inc. (NYSE:NUVB) Receives Consensus Recommendation of "Buy" from BrokeragesJuly 7, 2025 | marketbeat.comNuvation Bio Inc. (NUVB) latest stock news and headlines - Yahoo FinanceJuly 2, 2025 | uk.finance.yahoo.comNuvation Bio (NYSE:NUVB) Stock Price Up 8% - Time to Buy?June 30, 2025 | marketbeat.comJMP Maintains “Market Outperform” on Nuvation (NUVB) for IBTROZI Launch PlansJune 29, 2025 | msn.comNuvation Bio (NYSE:NUVB) Sees Strong Trading Volume - Here's What HappenedJune 25, 2025 | marketbeat.comNuvation Bio's (NUVB) "Market Outperform" Rating Reaffirmed at JMP SecuritiesJune 25, 2025 | marketbeat.comRBC Capital Lowers PT on Nuvation Bio (NUVB) to $6 But Keeps a Buy RatingJune 24, 2025 | msn.comNuvation Bio jumps after insiders purchase shares worth over $1.1MJune 20, 2025 | msn.comNuvation Bio (NYSE:NUVB) Shares Gap Up - Here's WhyJune 20, 2025 | marketbeat.comFounder of Nuvation Bio David Hung Buys More StockJune 20, 2025 | finance.yahoo.comNuvation Bio price target lowered to $6 from $10 at RBC CapitalJune 18, 2025 | investing.comNuvation Bio: A Justified Fall Based On Post-Marketing RequirementsJune 18, 2025 | seekingalpha.comRoyal Bank of Canada Has Lowered Expectations for Nuvation Bio (NYSE:NUVB) Stock PriceJune 17, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Shares Gap Down - Time to Sell?June 16, 2025 | marketbeat.comOnco360 Has Been Selected as a National Specialty Pharmacy Partner for IBTROZI™ (taletrectinib), Manufactured by Nuvation Bio Inc.June 16, 2025 | globenewswire.comNuvation Bio price target maintained at $6 by Citizens JMPJune 14, 2025 | investing.comNuvation Bio’s SWOT analysis: FDA approval boosts stock prospectsJune 14, 2025 | investing.comNuvation Bio (NYSE:NUVB) Downgraded to "Sell" Rating by Wall Street ZenJune 14, 2025 | marketbeat.comNuvation Bio Stock Short Interest Report | NYSE:NUVB | BenzingaJune 13, 2025 | benzinga.comUS FDA approves Nuvation Bio's rare lung cancer drugJune 13, 2025 | msn.comNuvation Bio (NYSE:NUVB) Trading Down 5.5% - Here's What HappenedJune 12, 2025 | marketbeat.comNuvation Bio Inc. (NYSE:NUVB) Given Average Rating of "Buy" by BrokeragesJune 12, 2025 | marketbeat.comU.S. Food and Drug Administration Approves Nuvation Bio’s IBTROZI™ (taletrectinib), a Next-Generation Oral Treatment for Advanced ROS1-Positive Non-Small Cell Lung CancerJune 11, 2025 | sg.finance.yahoo.comNuvation Bio granted FDA approval for lung cancer therapy IbtroziJune 11, 2025 | msn.comWedbush Reaffirms Outperform Rating for Nuvation Bio (NYSE:NUVB)June 11, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Sees Unusually-High Trading Volume - Still a Buy?June 11, 2025 | marketbeat.comUS FDA approves Nuvation Bio's lung cancer therapyJune 11, 2025 | reuters.comU.S. Food and Drug Administration Approves Nuvation Bio's IBTROZI™ (taletrectinib), a Next-Generation Oral Treatment for Advanced ROS1-Positive Non-Small Cell Lung CancerJune 11, 2025 | businesswire.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $925,000 Holdings in Nuvation Bio Inc. (NYSE:NUVB)June 11, 2025 | marketbeat.comNuvation Bio: Judgement Day Grows CloserJune 10, 2025 | seekingalpha.comNuvation Bio Inc. (NYSE:NUVB) Shares Sold by Squarepoint Ops LLCJune 7, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Raised to Hold at Wall Street ZenJune 6, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Trading 8.3% Higher - Time to Buy?June 3, 2025 | marketbeat.comNuvation Bio's (NUVB) "Market Outperform" Rating Reiterated at JMP SecuritiesJune 2, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Stock Price Down 4.6% - What's Next?May 31, 2025 | marketbeat.comNuvation Bio Inc. (NYSE:NUVB) Shares Acquired by Millennium Management LLCMay 29, 2025 | marketbeat.comNuvation Bio stockholders approve board members and executive payMay 25, 2025 | uk.investing.comNuvation Bio’s SWOT analysis: taletrectinib approval could transform stock outlookMay 23, 2025 | uk.investing.comNorthern Trust Corp Acquires 563,627 Shares of Nuvation Bio Inc. (NYSE:NUVB)May 23, 2025 | marketbeat.comNuvation Bio To Present New Data from Pivotal Clinical Studies of Taletrectinib in Advanced ROS1-Positive Non-Small Cell Lung Cancer at ASCO 2025 Annual MeetingMay 21, 2025 | businesswire.comWexford Capital LP Purchases 294,452 Shares of Nuvation Bio Inc. (NYSE:NUVB)May 21, 2025 | marketbeat.comNuvation Bio Inc. (NYSE:NUVB) Receives Average Recommendation of "Buy" from BrokeragesMay 20, 2025 | marketbeat.com4,164,178 Shares in Nuvation Bio Inc. (NYSE:NUVB) Bought by MPM Bioimpact LLCMay 16, 2025 | marketbeat.comDimensional Fund Advisors LP Cuts Position in Nuvation Bio Inc. (NYSE:NUVB)May 16, 2025 | marketbeat.comNuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Entrectinib at ISPOR 2025May 13, 2025 | businesswire.comWedbush Issues Positive Outlook for Nuvation Bio EarningsMay 13, 2025 | marketbeat.com Get Nuvation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVB and its competitors with MarketBeat's FREE daily newsletter. Email Address NUVB Media Mentions By Week NUVB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NUVB News Sentiment▼0.430.97▲Average Medical News Sentiment NUVB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NUVB Articles This Week▼44▲NUVB Articles Average Week Get Nuvation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Kymera Therapeutics News MorphoSys News HUTCHMED News Ultragenyx Pharmaceutical News Alvotech News Amneal Pharmaceuticals News Mirum Pharmaceuticals News Catalyst Pharmaceuticals News Arrowhead Pharmaceuticals News ImmunityBio News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NUVB) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvation Bio Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvation Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
